medication reconciliation intervention
Othermedication reconciliation intervention comprises medication reconciliation on admission and discharge, bedside medication counseling and take-home medication list
NCT Number: NCT02805270
The implementation of a medication reconciliation intervention including: medication reconciliation on admission and discharge, bedside medication counselling and take-home medication list, on the development of adverse drug events within 30 days post discharge as primary outcome. Secondary outcome is the evaluation of its impact on health care resource utilization
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
This is a randomized controlled trial in 587 patients randomized to intervention and usual care. The intervention is medication reconciliation on admission and discharge, bedside medication counselling and take-home medication list. Usual care is ward pharmacy practice. The primary outcomes are preventable and potential adverse drug events at 30 days post discharge. The secondary outcome is health care utilization: length of stay, emergency room visits, unplanned hospital visits, readmissions and travel abroad to seek medical attention.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
medication reconciliation intervention comprises medication reconciliation on admission and discharge, bedside medication counseling and take-home medication list
Time frame: 30 days
Time frame: 30 days
Time frame: 30 days
Time frame: 30 days
Time frame: 30 days
Time frame: 30 days
Sultan Qaboos University
Other
Implementation of a Medication Reconciliation Intervention and Its Impact on the Rate of ADEs and Healthcare Utilization 30 Days Following Discharge From the Hospital. A Randomized Controlled Trial.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01091038
Adverse Drug Events, Chemically-Induced Disorders
Indianapolis, Indiana, United States
View Trial DetailsNCT04692220
Adverse Drug Events, Chemically-Induced Disorders
Montpellier, France
View Trial DetailsNCT02482025
Adverse Drug Events, Chemically-Induced Disorders
Boston, Massachusetts, United States
View Trial DetailsNCT02059044
Adverse Drug Events, Chemically-Induced Disorders
Montreal, Quebec, Canada
View Trial Details